Total Payments
$416.12
2019 Payments
$72.33
Companies
12
Transactions
23
Medicare Patients
1,209
Medicare Billing
$118,684
Payment Breakdown by Category
Food & Beverage$416.12 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $416.12 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $116.70 | 6 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $41.44 | 3 | $0 (2017) |
| Amarin Pharma Inc. | $39.49 | 2 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $38.79 | 2 | $0 (2017) |
| Amgen Inc. | $37.28 | 2 | $0 (2017) |
| Allergan Inc. | $33.20 | 2 | $0 (2017) |
| Boston Scientific Corporation | $28.39 | 1 | $0 (2019) |
| Abbott Laboratories | $20.70 | 1 | $0 (2018) |
| Lilly USA, LLC | $16.90 | 1 | $0 (2017) |
| Astellas Pharma US Inc | $15.54 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $72.33 | 3 | GlaxoSmithKline, LLC. ($43.94) |
| 2018 | $58.68 | 3 | GlaxoSmithKline, LLC. ($37.98) |
| 2017 | $285.11 | 17 | Merck Sharp & Dohme Corporation ($41.44) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/09/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological), MENVEO | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: VACCINES | ||||||
| 05/15/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological), MENVEO, SHINGRIX | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: VACCINES | ||||||
| 03/20/2019 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: STRUCTURAL HEART | ||||||
| 09/28/2018 | Abbott Laboratories | FreeStyle Libre blood glucose Flash Monitoring System (Device) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Diabetes Care | ||||||
| 07/18/2018 | GlaxoSmithKline, LLC. | BEXSERO (Biological), MENVEO, SHINGRIX | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: VACCINES | ||||||
| 02/21/2018 | GlaxoSmithKline, LLC. | BEXSERO (Biological), MENVEO | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: VACCINES | ||||||
| 11/08/2017 | GlaxoSmithKline, LLC. | FLUARIX (Biological), BOOSTRIX, ENGERIX-B | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: VACCINES | ||||||
| 07/20/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/12/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ZOSTAVAX | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/28/2017 | Teva Pharmaceuticals USA, Inc. | QVAR (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Respiratory | ||||||
| 06/15/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Endocrinology | ||||||
| 06/14/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Hypertriglyceridemia | ||||||
| 06/08/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: NEUROSCIENCE | ||||||
| 06/02/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: RESPIRATORY | ||||||
| 05/24/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Urology | ||||||
| 04/19/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Diabetes | ||||||
| 04/19/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ZOSTAVAX | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/29/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/16/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/15/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Hypertriglyceridemia | ||||||
| 03/02/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Endocrinology | ||||||
| 01/12/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 256 | 317 | $69,310 | $29,649 |
| 2022 | 6 | 269 | 341 | $69,810 | $29,878 |
| 2021 | 8 | 302 | 368 | $70,665 | $31,170 |
| 2020 | 10 | 382 | 429 | $71,557 | $27,988 |
Total Patients
1,209
Total Services
1,455
Medicare Billing
$118,684
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 81 | 134 | $31,490 | $11,687 | 37.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 50 | 50 | $12,000 | $6,691 | 55.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $13,350 | $5,346 | 40.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 38 | $5,890 | $2,363 | 40.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 26 | 26 | $4,640 | $1,960 | 42.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 30 | 31 | $1,085 | $993.55 | 91.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $855.00 | $608.95 | 71.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 105 | 168 | $39,480 | $13,964 | 35.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 59 | 59 | $14,160 | $8,147 | 57.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 32 | 34 | $5,440 | $2,377 | 43.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 34 | $5,270 | $2,332 | 44.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 11 | 11 | $4,235 | $1,957 | 46.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 33 | 35 | $1,225 | $1,101 | 89.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 95 | 143 | $32,855 | $12,475 | 38.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 57 | 57 | $13,680 | $8,179 | 59.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 20 | 20 | $7,700 | $3,625 | 47.1% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 32 | 32 | $5,120 | $2,059 | 40.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 23 | $3,485 | $1,567 | 45.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 18 | 28 | $4,200 | $1,560 | 37.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 23 | 27 | $2,295 | $1,030 | 44.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 38 | 38 | $1,330 | $673.40 | 50.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 85 | 117 | $25,698 | $8,443 | 32.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 44 | 44 | $10,560 | $5,539 | 52.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 15 | 15 | $5,650 | $2,758 | 48.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 51 | 55 | $8,250 | $2,525 | 30.6% |
About Dr. Ali Kadkhoda, DO
Dr. Ali Kadkhoda, DO is a Family Medicine healthcare provider based in Bala Cynwyd, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2010. The National Provider Identifier (NPI) number assigned to this provider is 1699094607.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ali Kadkhoda, DO has received a total of $416.12 in payments from pharmaceutical and medical device companies, with $72.33 received in 2019. These payments were reported across 23 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($416.12).
As a Medicare-enrolled provider, Kadkhoda has provided services to 1,209 Medicare beneficiaries, totaling 1,455 services with total Medicare billing of $118,684. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Bala Cynwyd, PA
- Active Since 06/01/2010
- Last Updated 02/06/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1699094607
Products in Payments
- BEXSERO (Biological) $81.92
- JANUVIA (Drug) $41.44
- Vascepa (Drug) $39.49
- ENTRESTO (Drug) $38.79
- Prolia (Biological) $37.28
- NAMZARIC (Drug) $33.20
- WATCHMAN (Device) $28.39
- FreeStyle Libre blood glucose Flash Monitoring System (Device) $20.70
- FLUARIX (Biological) $18.67
- TRULICITY (Drug) $16.90
- ANORO (Drug) $16.11
- Myrbetriq (Drug) $15.54
- QVAR (Drug) $14.27
- XARELTO (Drug) $13.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bala Cynwyd
Dr. Yuliya Gombar, D.o, D.O
Family Medicine — Payments: $4,074
Family Medicine $4,074
Dr. Andrew Kirschner, D.o, D.O
Family Medicine — Payments: $2,184
Family Medicine $2,184
Leslie Partem, Md, MD
Family Medicine — Payments: $709.27
Family Medicine $709.27
Megan Jones, D.o, D.O
Family Medicine — Payments: $621.81
Family Medicine $621.81
Dr. Richard Watson, D.o, D.O
Family Medicine — Payments: $619.57
Family Medicine $619.57
Dr. Tamara Fedec, D.o, D.O
Family Medicine — Payments: $604.25
Family Medicine $604.25